Insider Trading & Ownership - ARSENAULT KAITLYN

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARSENAULT KAITLYN
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-15
Sale
2024-11-19
9:57 pm
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
43,396$4.9925$216,652166,342
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-28
Option Award
2024-10-30
8:32 pm
N/A
2034-10-27
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
125,000$0125,000
(Direct)
View
2024-02-29
Option Award(A)
2024-03-04
06:15 am
N/A
2034-03-01
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
100,000$0284,738
(Direct)
View
2024-02-29
Option Award
2024-03-01
6:42 pm
N/A
2034-03-01
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
100,000$0285,738
(Direct)
View
2023-11-06
Option Award
2023-11-06
8:29 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
160,262$0231,174
(Direct)
View
2023-08-25
Option Award
2023-08-29
6:53 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYEARSENAULT KAITLYN
Chief Financial Officer
16,727,648$017,727,648
(Direct)
View
2021-12-14
Option Award
2021-12-16
6:59 pm
N/A
2031-12-14
Skye Bioscience Inc.SKYEArsenault Kaitlyn Melanie
Chief Financial Officer
2,770,000$02,770,000
(Direct)
View
2021-10-04
Option Award
2021-10-05
8:42 pm
N/A
2031-10-04
Skye Bioscience Inc.SKYEArsenault Kaitlyn Melanie
Chief Financial Officer
1,600,000$02,000,000
(Direct)
View

Ownership
2021-10-05
8:40 pm
N/A
2031-09-14
Skye Bioscience Inc.SKYEArsenault Kaitlyn Melanie
Chief Financial Officer
0$0400,000
(Direct)
View
(A) Indicate amendment filing.